Literature DB >> 35882507

Pathophysiological Implications of Variability in Blood Tacrolimus Levels in Pediatric and Adolescent Kidney Transplant Recipients.

Rachel Becker-Cohen1.   

Abstract

Entities:  

Keywords:  adolescent; children; kidney transplantation; tacrolimus

Year:  2022        PMID： 35882507      PMCID： PMC9435984          DOI： 10.2215/CJN.06640622

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  What is the intrapatient variability of mycophenolic acid trough levels?

Authors:  Ekaterina K Todorova; Shih-Han S Huang; Marta C Kobrzynski; Guido Filler
Journal:  Pediatr Transplant       Date:  2015-07-23

2.  Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.

Authors:  Benaya Rozen-Zvi; Shira Schneider; Shelly Lichtenberg; Hefziba Green; Ori Cohen; Uzi Gafter; Avry Chagnac; Eytan Mor; Ruth Rahamimov
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

3.  Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients-an international CTS registry analysis.

Authors:  Annika Gold; Burkhard Tönshoff; Bernd Döhler; Caner Süsal
Journal:  Transpl Int       Date:  2020-09-21       Impact factor: 3.782

4.  Is noncompliance among adolescent renal transplant recipients inevitable?

Authors:  Sofia Feinstein; Rami Keich; Rachel Becker-Cohen; Choni Rinat; Shepard B Schwartz; Yaacov Frishberg
Journal:  Pediatrics       Date:  2005-04       Impact factor: 7.124

5.  Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.

Authors:  Sonia Solomon; Adriana Colovai; Marcela Del Rio; Nicole Hayde
Journal:  Pediatr Nephrol       Date:  2019-11-15       Impact factor: 3.714

6.  Impact of once-daily ER-Tac on trough concentration variability in a stable AYA renal transplant recipient cohort.

Authors:  Mary Moss Chandran; Eliza Blanchette; Jens Goebel; Margret Bock
Journal:  Pediatr Transplant       Date:  2021-05-18

7.  C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients.

Authors:  Nicole Hayde; Sonia Solomon; Elif Caglar; Jasmine Ge; Eros Qama; Adriana Colovai
Journal:  Pediatr Transplant       Date:  2020-11-01

8.  Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort.

Authors:  Scott Davis; Christopher Wiebe; Kristen Campbell; Cheri Anobile; Michael Aubrey; Erik Stites; Monica Grafals; Elizabeth Pomfret; Peter Nickerson; James E Cooper
Journal:  Am J Transplant       Date:  2020-10-11       Impact factor: 8.086

9.  High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes.

Authors:  Aleixandra Mendoza Rojas; Dennis A Hesselink; Nicole M van Besouw; Marjolein Dieterich; Ronella de Kuiper; Carla C Baan; Teun van Gelder
Journal:  Ther Drug Monit       Date:  2022-04-07       Impact factor: 3.118

10.  A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.

Authors:  David K Hooper; Charles D Varnell; Kristin Rich; Adam Carle; John Huber; Farida Mostajabi; Devesh Dahale; Ahna L H Pai; Jens Goebel; Avani C Modi
Journal:  Am J Kidney Dis       Date:  2021-08-03       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.